Status:
COMPLETED
Prospective Single-center Long-term Observation of the SL-PLUS® MIA Stem
Lead Sponsor:
Smith & Nephew Orthopaedics AG
Conditions:
Primary Total Hip Arthroplasty
Eligibility:
All Genders
40-80 years
Brief Summary
Summary from initial protocol Goal: Validation of the uncoated SL-PLUS® MIA stem within an observation study Study design: prospective, single-center, observational, non-comparative study Study pop...
Eligibility Criteria
Inclusion
- Patients with primary or secondary hip osteoarthritis
- Patients scheduled for a first implantation
- Age at the time of surgery 40-80 years
Exclusion
- Destruction of the acetabulum
- Deformation of the hip joint
- Deformation of the proximal femur
- Revision of failed hip endoprostheses
- Acute or recent infection of the joint or its surrounding region
- Acute or chronic systemic infections
- Marked atrophy or deformation of the upper femur
- Muscle atrophy or a neuromuscular disease
- Pathological fractures
- Per- to subtrochanteric fractures
- Conditions that would prevent secure anchoring of the hip prosthesis
- Obese patients with a BMI \>35
- Patients not expected to have a successful rehabilitation
Key Trial Info
Start Date :
July 22 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 11 2019
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT04122157
Start Date
July 22 2007
End Date
November 11 2019
Last Update
January 6 2026
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.